Automatic sale by software - loss prevention
3. Buy Open
(Software awaits cheaper courses
that is a good thing).
Equity trading without stress is recovering
Yield 10 current trend is down
SF
|
RS 1/40
seekingalpha.com/news/...d10-bio-to-reverse-split-shares-1-40
Zahlen für Q1/20
"The Company anticipates total net cash usage during 2020 in a range of approximately $9.0 million to $9.5 million."
"The Company's present capital resources are expected to fund its planned operations into the second quarter of 2021. Yield10's ability to continue operations after its current cash resources are exhausted depends on its ability to obtain additional financing, including public or private equity financing, secured or unsecured debt financing, and receipt of additional government research grants, as well as licensing or other collaborative arrangements."
ir.yield10bio.com/news-releases/...irst-quarter-2020-financial
5,2 Mio. $ Offering
ir.yield10bio.com/news-releases/...-52-million-public-offering
12,7 Mio. $ Offering
seekingalpha.com/news/...eld10-bio-secures-127m-capital-raise
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
1 | Yield10 Bioscience - 3.11 $ - (YTEN) | Nanostox | Nanostox | 08.05.23 22:23 | ||
2 | 34 | Metabolix mit Potenzial | Biotechspezialx | Vassago | 25.04.21 03:01 | |
5 | 8 | Bioplastik in den Startlöchern | Mme.Eugenie | Mme.Eugenie | 06.10.10 11:08 |